Silverfin false false 30/06/2024 01/07/2023 30/06/2024 J Early 01/05/2022 A M Patel 17/01/2017 M C Stone 01/01/2021 07 November 2024 The principal activity of the company is that of a pharmacy. 06267233 2024-06-30 06267233 bus:Director1 2024-06-30 06267233 bus:Director2 2024-06-30 06267233 bus:Director3 2024-06-30 06267233 2023-06-30 06267233 core:CurrentFinancialInstruments 2024-06-30 06267233 core:CurrentFinancialInstruments 2023-06-30 06267233 core:ShareCapital 2024-06-30 06267233 core:ShareCapital 2023-06-30 06267233 core:RetainedEarningsAccumulatedLosses 2024-06-30 06267233 core:RetainedEarningsAccumulatedLosses 2023-06-30 06267233 core:Vehicles 2023-06-30 06267233 core:FurnitureFittings 2023-06-30 06267233 core:Vehicles 2024-06-30 06267233 core:FurnitureFittings 2024-06-30 06267233 bus:OrdinaryShareClass1 2024-06-30 06267233 2023-07-01 2024-06-30 06267233 bus:FilletedAccounts 2023-07-01 2024-06-30 06267233 bus:SmallEntities 2023-07-01 2024-06-30 06267233 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 06267233 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 06267233 bus:Director1 2023-07-01 2024-06-30 06267233 bus:Director2 2023-07-01 2024-06-30 06267233 bus:Director3 2023-07-01 2024-06-30 06267233 core:Vehicles 2023-07-01 2024-06-30 06267233 core:FurnitureFittings 2023-07-01 2024-06-30 06267233 2022-07-01 2023-06-30 06267233 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 06267233 bus:OrdinaryShareClass1 2022-07-01 2023-06-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 06267233 (England and Wales)

TAMAR VALLEY HEALTH LIMITED

Unaudited Financial Statements
For the financial year ended 30 June 2024
Pages for filing with the registrar

TAMAR VALLEY HEALTH LIMITED

Unaudited Financial Statements

For the financial year ended 30 June 2024

Contents

TAMAR VALLEY HEALTH LIMITED

BALANCE SHEET

As at 30 June 2024
TAMAR VALLEY HEALTH LIMITED

BALANCE SHEET (continued)

As at 30 June 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 61,377 75,632
61,377 75,632
Current assets
Stocks 30,919 27,438
Debtors 4 117,901 78,711
Cash at bank and in hand 244,619 199,332
393,439 305,481
Creditors: amounts falling due within one year 5 ( 317,906) ( 185,491)
Net current assets 75,533 119,990
Total assets less current liabilities 136,910 195,622
Provision for liabilities ( 15,344) ( 18,908)
Net assets 121,566 176,714
Capital and reserves
Called-up share capital 6 2 2
Profit and loss account 121,564 176,712
Total shareholders' funds 121,566 176,714

For the financial year ending 30 June 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Tamar Valley Health Limited (registered number: 06267233) were approved and authorised for issue by the Board of Directors on 07 November 2024. They were signed on its behalf by:

J Early
Director
TAMAR VALLEY HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2024
TAMAR VALLEY HEALTH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Tamar Valley Health Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Gunnislake Health Centre, The Orchard, Gunnislake, PL18 9JZ, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the sale of goods is recognised when the goods are physically delivered to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on tax rates and laws substantively enacted at the balance sheet date. Deferred tax assets and liabilities are not discounted.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a reducing balance basis over its expected useful life, as follows:

Vehicles 25 % reducing balance
Fixtures and fittings 15 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Provision is made for obsolete, slow-moving or defective items where appropriate.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 6 5

3. Tangible assets

Vehicles Fixtures and fittings Total
£ £ £
Cost
At 01 July 2023 50,299 63,510 113,809
At 30 June 2024 50,299 63,510 113,809
Accumulated depreciation
At 01 July 2023 21,204 16,973 38,177
Charge for the financial year 7,274 6,981 14,255
At 30 June 2024 28,478 23,954 52,432
Net book value
At 30 June 2024 21,821 39,556 61,377
At 30 June 2023 29,095 46,537 75,632

4. Debtors

2024 2023
£ £
Trade debtors 110,153 74,646
Prepayments 7,748 4,065
117,901 78,711

5. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 80,797 95,443
Accruals 2,187 7,981
Taxation and social security 82,123 31,778
Other creditors 152,799 50,289
317,906 185,491

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
2 Ordinary shares of £ 1.00 each 2 2

7. Related party transactions

Other related party transactions

2024 2023
£ £
Amounts due from / (payable to) related party 150,331 50,289

Tamar Valley Health
(The directors of the company are all partners within the Tamar Valley Health partnership)

During the year a loan account existed between the company and the Tamar Valley Health. The company made advances to the practice in the year amounting to £162,988. Repayments were received from the partnership during the year amounting to £263,030. The loan between the company and the partnership is interest free and repayable on demand.